Nelia Hernández

Pennsylvania State University — United States

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

24h-index2.1kcitations131works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug-Induced Hepatotoxicity and Protection(46), Liver Disease Diagnosis and Treatment(43), Hepatitis C virus research(27), Pharmacogenetics and Drug Metabolism(18), Hepatitis B Virus Studies(16)

Publications130 total

Mycorrhizal networks transfer jasmonic acid to recruit pathogen-suppressors
Trends in Microbiology·2025· 1 citedOpen Access
FIBRATES SEEM TO BE EQUALLY EFFECTIVE AS SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS, WITH BIOCHEMICAL RESPONSE PLATEAUING AT 6 MONTHS
Annals of Hepatology·2025Open Access
AMA-NEGATIVE PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: A DISTINCT SUBSET WITH LOWER TREATMENT RESPONSE
Annals of Hepatology·2025Open Access
DRUG-INDUCED DUCTOPENIA IN THE SPANISH AND LATINDILI REGISTRIES
Annals of Hepatology·2025Open Access
REVIRAL: ROADMAP FOR THE ELIMINATION OF VIRAL HEPATITIS IN LATIN AMERICA
Annals of Hepatology·2025Open Access
STATIN-INDUCED LIVER INJURY: DATA FROM URUGUAYAN PROSPECTIVE HEPATOTOXICITY REGISTRY.
Annals of Hepatology·2025Open Access
STEATOSIS AND HEPATIC FIBROSIS IN PEDIATRIC POPULATION WITH OVERWEIGHT OR OBESITY BY TRANSITION ELASTOGRAPHY.
Annals of Hepatology·2025Open Access
In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets
Farmacia Hospitalaria·2025Open Access
Periodic Assessment of Trajectories of Housing, Homelessness, and Health Study (PATHS): Protocol for a Prospective Cohort Study of People Experiencing Homelessness
JMIR Research Protocols·2025Open Access
Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country‐Specific and <scp>WHO</scp> 2024 Guidelines
Journal of Viral Hepatitis·2025
REVIRAL: roadmap for the elimination of viral hepatitis in Latin America
Frontiers in Public Health·2025· 1 citedOpen Access
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Annals of Hepatology·2025· 28 citedOpen Access
Stanozolol-induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype at Presentation
Journal of Clinical and Experimental Hepatology·2025· 1 cited
Psychological Symptoms and Academic Dropout in Higher Education: A Six-Year Cohort Study
Journal of College Student Mental Health·2025· 11 cited
P-2 RECAM VS. RUCAM: ADVANCING THE DIAGNOSIS OF IDIOSYNCRATIC DILI WITH A REVISED ELECTRONIC APPROACH.
Annals of Hepatology·2024Open Access
OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B
Annals of Hepatology·2024Open Access
OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS
Annals of Hepatology·2024· 1 citedOpen Access
P-76 MANIFESTATIONS OF PORTAL HYPERTENSION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY: PRELIMINARY DATA
Annals of Hepatology·2024Open Access
20651. UTILIDAD DE LA BIOIMPEDANCIA ELÉCTRICA COMO BIOMARCADOR EN LA DISTROFIA MIOTÓNICA TIPO I
Neurology Perspectives·2024Open Access
51 Improving Resident Racial and Ethnic Diversity
Annals of Emergency Medicine·2024
page 1 of 7Next →

Frequent Co-authors

Fernando Bessone(29), Raúl J. Andrade(25), M. Isabel Lucena(24), Inmaculada Medina‐Cáliz(18), Marco Arrese(17), Manuel Mendizábal(15), Raymundo Paraná(14), Mercedes Robles‐Díaz(13), Camilla Stephens(13), Ezequiel Ridruejo(13), María Isabel Schinoni(9), Daniela Chiodi(8), Martín Tagle(8), Federico Tanno(8), Nahúm Méndez‐Sánchez(7), Enrique Carrera(7), Margarita Anders(7), Javier Brahm(7), Miren García‐Cortés(7), Vinícius Nunes(7)